Abbott Laboratories (ABT)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Abbott Laboratories (ABT) is down 28.6% since the beginning of the year. At $88 per share, ABT is trading 36.4% below its 52-week high of $139. Investors who bought $1,000 worth of ABT shares 5 years ago would now be looking at an investment worth $880.

Abbott Laboratories (ABT) has returned -28.63% so far this year and -32.16% over the past 12 months. Over the last ten years, ABT has returned 10.94% per year, falling short of the S&P 500 Index benchmark, which averaged 13.54% annually.

Based on dividend-adjusted daily data since Apr 6, 1983, ABT's average daily return is +0.06%, while the average monthly return is +1.15%. At this rate, an investment would double in approximately 5.1 years.

Historically, 61% of months were positive and 39% were negative. The best month was Mar 1986 with a return of +22.1%, while the worst month was Jun 2002 at -20.7%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 4 months.

On a daily basis, ABT closed higher 50% of trading days. The best single day was Jul 25, 2002 with a return of +12.5%, while the worst single day was Jun 11, 2002 at -16.1%.

Abbott Laboratories has an annualized alpha of 7.36%, beta of 0.73, and R2 of 0.27 versus S&P 500 Index. Calculated based on daily prices since April 06, 1983.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (79.45%) than losses (61.23%) - typical of diversified or defensive assets.
• R2 of 0.27 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ABT ranks 4 for risk / return — in the bottom 4% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

Abbott Laboratories provided a 2.76% dividend yield over the last twelve months, with an annual payout of $2.44 per share. The company has been increasing its dividends for 11 consecutive years.

The table displays the monthly dividend distributions for Abbott Laboratories. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Abbott Laboratories. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Abbott Laboratories was 45.66%, occurring on Jul 23, 2002. Recovery took 621 trading sessions.

The current Abbott Laboratories drawdown is 35.36%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Abbott Laboratories over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Abbott Laboratories is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.